Recent Study: Russia Pharmaceutical Market Overview

New Pharmaceuticals market report from Datamonitor: "Russia Pharmaceutical Market Overview Pharma companies target Russia despite the challenges it presents"
May 27, 2011 - PRLog -- Introduction

The Russian pharmaceutical market generated $10.1 billion in sales in 2009, growing by 14.5% between 2008 and 2009. Key growth drivers include a preference for foreign drugs rather than domestically manufactured products. The government has also designated healthcare a strategic priority for the country's future development which is expected to stimulate Russia's pharmaceutical market.


* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Russia
* Assesses the size of the Russian pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies
* Examines the Russian generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion
* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

Full Report Details at


Private health expenditure accounts for one third of all healthcare costs of which 82%% is met by out-of-pocket costs due to insufficient availability of healthcare services and medicines through the public healthcare system, as well as the widespread informal payments for healthcare services.

Registration of drugs in the Russian Federation remains a cumbersome and lengthy procedure which lacks clarity and transparency and is subject to frequent change. Cultural and language barriers present further obstacles to foreign companies ""going it alone"".

The generics industry is complex and fragmented, dominated by a small number of international generics manufacturers. Generics produced by these companies enjoy preferential uptake driven by their perceived superiority to domestically manufactured generics, with Russians choosing to pay higher prices for guaranteed quality.

Reasons to Purchase

* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in Russia
* Quantify the size and growth of the prescription pharmaceutical market in Russia, analyzing key therapy areas, brands and companies
* Assess drivers and resistors of generic and biosimilars uptake in Russia

Partial Table of Contents:

About the Healthcare Strategic Analysis Team
Geographic specific reports:
Global issue reports:
1. Executive Summary
Strategic scoping and focus
Key Findings
Russia - Socio-demographic and economic analysis
Socio-demographic trends
Socio-economic trends
Russia - Healthcare system and drug regulatory analysis
Healthcare expenditure
Healthcare insurance
Regulatory issues
Pricing and reimbursement issues
Russia - Prescription pharmaceutical sales analysis
Pharmaceutical market size
Leading therapy areas
Leading pharmaceutical brands
Leading pharmaceutical companies
Russia - Drug expiry analysis
Generics market
Brand erosion post patent expiry
Biosimilars market
Russia - Drug Industry Infrastructure analysis
Pharmaceutical industry infrastructure overview
Related reports
Upcoming related reports
Table of Contents
2. Russia - Socio-demographic and economic analysis
Russia - Key findings
Socio-demographic trends
Socio-economic trends
Russia - Demographic trends
Population in Russia expected to decline rapidly
Population growth rate in Russia remains low due to low birth rates
Proportion of elderly people will remain lower than in all other markets
Life expectancy in Russia is poor and will remain so
Russia - Disease burden in Russia
Cardiovascular diseases and injuries are the leading cause of death and account for the highest disease burden in Russia
High level of preventable deaths in Russia
HIV/AIDS presents a worrying trend in Russia
Russia - Political climate
The political climate in Russia has undergone recent changes
Russia remains a centralized country with power centered on Moscow
Russia - Economic climate
Economy - recovery post-recession is slow but will gain momentum from 2010
Economic growth is impacted by income inequality in Russia
Russia - Business environment
Although impediments to investing in Russia remain, the government is prioritizing healthcare
The recession has impacted unemployment levels
Russia has a uniform tax rate
Pharmaceuticals are subject to a reduced VAT rate of 10%
Corruption significantly impedes foreign investment in Russia
Local knowledge is critical for business success
3. Russia - Healthcare system and drug regulatory analysis
Russia - Key findings
Healthcare expenditure
Healthcare insurance
Regulatory issues
Pricing and reimbursement issues
Russia - Healthcare expenditure
Russia - Healthcare System
Key bodies regulating the healthcare system
Ministry of Health and Social Development (MOH)
Parallel healthcare system
The Federal and Territorial Mandatory Health Insurance Fund
Additional experts and coordinating bodies
Primary versus hospital healthcare in Russia
In efficiencies in the primary care system lead to over-referral, over-hospitalization and over treatment
Significant disparities exist in the distribution of physicians and healthcare facilities
Access to healthcare is especially problematic for the poor population...
...but healthcare modernization plans are in place
Project 'Zdorovie' is focused on developing healthcare in Russia

Full Table of Contents is available at:

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
Email:*** Email Verified
Tags:Pharmaceutical, Healthcare, Generic, Infrastructure, Drug, Manufacturing, Erosion, Biosimilar, Russian, Therapy
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Daily News
Weekly News

Like PRLog?
Click to Share